Broadline

RSS

eprinomectin, fipronil, praziquantel, (S)-methoprene

Authorised
This medicine is authorised for use in the European Union.

Overview

Broadline is a veterinary medicine used to treat cats with, or at risk of, mixed infestations by tapeworms, roundworms and external parasites (fleas, ticks, and a burrowing mite called Notoedres cati which is a cause of mange). The product is to be used only when all three groups of parasites are targeted at the same time.

For external parasites, Broadline treats flea infestations and prevents new infestations for at least one month; it also prevents environmental flea contamination for over a month. It may also be used as part of a treatment strategy for flea allergy dermatitis (an allergic reaction to flea bites). It treats tick infestations and prevents new infestations for up to three weeks.

For worms, Broadline is used to treat tapeworms, roundworms and hookworms in the gut as well as a type of worm that infects the bladder and two types of feline lungworm. Broadline can also be used to prevent heartworm disease for one month.

Broadline contains four active substances: fipronil, (S)-methoprene, eprinomectin and praziquantel.

This EPAR was last updated on 09/01/2020

Authorisation details

Product details
Name
Broadline
Agency product number
EMEA/V/C/002700
Active substance
eprinomectin, fipronil, praziquantel, (S)-methoprene
International non-proprietary name (INN) or common name
eprinomectin, fipronil, praziquantel, (S)-methoprene
Species
Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP54AA54
Publication details
Marketing-authorisation holder
Boehringer Ingelheim Vetmedica GmbH
Revision
9
Date of issue of marketing authorisation valid throughout the European Union
04/12/2013
Contact address

Binger Strasse 173
55216 Ingelheim am Rhein
Germany

Product information

17/12/2019 Broadline - EMEA/V/C/002700 - T/0028

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Antiparasitic products
  • insecticides and repellents
  • Avermectins
  • eprinomectin, combinations

Therapeutic indication

For cats with, or at risk from mixed infestations by cestodes, nematodes and ectoparasites. The veterinary medicinal product is exclusively indicated when all three groups are targeted at the same time.

Ectoparasites

  • Treatment and prevention of infestations by fleas (Ctenocephalides felis). Elimination of fleas within 24 hours. One treatment prevents further infestations for at least one month.
  • Prevention of environmental flea contamination by inhibiting the development of flea immature stages (eggs, larvae and pupae) for over a month.
  • The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
  • Treatment and prevention of infestations by ticks (Ixodes ricinus). Elimination of ticks within 48 hours. One treatment prevents further infestations for up to 3 weeks.
  • Treatment of notoedric mange (Notoedres cati).

Cestodes

  • Treatment of infestations with tapeworms (Dipylidium caninum, Taenia taeniaeformis, Echinococcus multilocularis, Joyeuxiella pasqualei (adult), and Joyeuxiella fuhrmanni (adult)).

Nematodes

  • Treatment of infestations with gastrointestinal nematodes (L3, L4 larvae and adults of Toxocara cati, adults of Toxascaris leonina, L4 larvae and adults of Ancylostoma tubaeforme and Ancylostoma ceylanicum, and adults of Ancylostoma brazilienze).
  • Treatment of infestations with feline lungworms (L3 larvae, L4 larvae and adults of Aelurostrongylus abstrusus, L4 larvae and adults of Troglostrongylus brevior).
  • Treatment of infestations with vesical worms (Capillaria plica).
  • Prevention of heartworm disease (Dirofilaria immitis larvae) for one month.

Assessment history

Changes since initial authorisation of medicine

How useful was this page?

Add your rating